(Q40518673)

21 September 2017

title

Acute negative inotropic effects of homocysteine are mediated via the endothelium (English)

1 reference

21 September 2017

0 references

Richard H Kennedy

1

1 reference

21 September 2017

Richard Owings

series ordinal

2

1 reference

21 September 2017

Nawal Shekhawat

series ordinal

3

1 reference

21 September 2017

Jacob Joseph

series ordinal

4

1 reference

21 September 2017

publication date

8 April 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

21 September 2017

published in

1 reference

21 September 2017

volume

287

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

H812-7

1 reference

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Determination of different species of homocysteine in human plasma by high-performance liquid chromatography with ultraviolet detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

EFFECT OF CORONARY PERFUSION PRESSURE OR CORONARY FLOW ON OXYGEN USAGE OF THE MYOCARDIUM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Total homocysteine and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Inhibition of K+ currents by homocysteine in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

On the mechanism of the inhibition of Na(+), K(+)-ATPase activity caused by homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Homocysteine reduces smooth muscle [Ca2+]i and constrictor responses of isolated arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01042.2003

10.1152/AJPHEART.01042.2003

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference